Ohad Hammer
Director/Board Member at Eyevensys SAS
Network origin in Ohad Hammer first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Precirix NV
 Precirix NV Pharmaceuticals: MajorHealth Technology Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium.
11
| Holding Company | Pharmaceuticals: Major | 11 |
Pontifax Management Co. Ltd.
 Pontifax Management Co. Ltd. Investment ManagersFinance Pontifax Management Co. Ltd. (Pontifax) is a venture capital firm founded in 2004 by Eliyahu Hurvitz. The firm is headquartered in Herzliya Pituach, Israel.
10
| Private Company | Investment Managers | 10 |
Eyevensys SAS
 Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.
9
| Holding Company | Miscellaneous Commercial Services | 9 |
Metabomed Ltd.
 Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Emergence Therapeutics AG
 Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ohad Hammer via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Chairman Chief Executive Officer | |
| University of Pennsylvania | College/University | Doctorate Degree Masters Business Admin | |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Masters Business Admin Graduate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Undergraduate Degree | |
| Weizmann Institute of Science | College/University | Doctorate Degree Doctorate Degree | |
| APOSENSE LTD | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ELECTREON WIRELESS LTD | Electrical Products | Director/Board Member Chairman | |
| PROTALIX BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman Chairman | |
| FATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
INSERM Transfert Initiative SAS
 INSERM Transfert Initiative SAS Investment ManagersFinance INSERM Transfert Initiative SAS is a venture capital fund that invests in companies located in France. It targets startups from the life sciences and biotechnology sectors, developing new medical practices with a strong intellectual property. It invests between €1 million and €3 million per company during mostly at pre-seed, seed and early-stages. | Investment Managers | Chairman Chairman | |
CollPlant Ltd.
 CollPlant Ltd. BiotechnologyHealth Technology CollPlant Ltd. specializes in the development and commercialization of medical products. It develops and commercialize tissue repair products for orthobiologics and advanced wound care markets. The company was founded by Tsafrir Feigin Yehuda and Oded Shoseyov in 2004 and is headquartered in Ness Ziona, Israel. | Biotechnology | Director/Board Member Director/Board Member | |
| SCISPARC LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
Nutrinia Ltd.
 Nutrinia Ltd. Pharmaceuticals: MajorHealth Technology Nutrinia Ltd. develops bioactive feed supplements for infant formulas and animal feed. The firm is involved in broad intellectual property protection, industrial processes envelopment, conducting additional clinical trials and obtaining regulatory approval for the supplementation of pre-term and infant formulas with Insulin. The company was founded by Naim Shehadeh in 2003 and is headquartered in Ramat-Gan, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
| Spearhead Investments (Bio) Ltd. | Director/Board Member Chairman | ||
| ERECH FINANCE CAHALACHA LTD | Medical Specialties | Director/Board Member Director/Board Member | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Amakem NV
 Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Medical/Nursing Services | Founder Director/Board Member | |
| COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Director/Board Member Director/Board Member | |
cCAM Biotherapeutics Ltd.
 cCAM Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology cCAM Biotherapeutics Ltd. is a preclinical-stage company engaging in the development of immunotherapies to treat cancer. The company was founded by Silvia Noiman and Gal Markel in 2010 and is headquartered in Hod Ha'Sharon, Israel. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| UROGEN PHARMA LTD. | Biotechnology | Director/Board Member Director/Board Member | |
OCON Medical Ltd.
 OCON Medical Ltd. Medical/Nursing ServicesHealth Services OCON Medical Ltd. engages in the research and development of intrauterine device. Its products include Intrauterine Ball IUB and IUB SCu300. The company was founded by Ilan Baram on 2008 and is headquartered in Modiin, Israel. | Medical/Nursing Services | Chairman Director/Board Member | |
Eloxx Pharmaceuticals Ltd.
 Eloxx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AELIS FARMA | Biotechnology | Director/Board Member Director/Board Member | |
Amolyt Pharma SAS
 Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Confo Therapeutics NV
 Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KEROS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VBI VACCINES INC. | Biotechnology | Director/Board Member Director/Board Member | |
BliNK Biomedical SAS
 BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
Aliment Capital Llc
 Aliment Capital Llc Investment ManagersFinance Aliment Capital LLC (Aliment Capital) is a venture capital subsidiary of Pontifax Management Co. Ltd. founded in 2014 by Philip Robert Erlanger and Ben Belldegrun. The firm is headquartered in California, United States. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| ACTICOR BIOTECH SAS | Biotechnology | Director/Board Member Director/Board Member | |
LB Pharmaceuticals, Inc.
 LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology LB Pharmaceuticals, Inc. provides pharmaceutical services. The company was founded by Vince Grattan and Zachary Prensky in 2015 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| Pontifax (Cayman) III LP | Investment Managers | Director/Board Member | |
Pontifax (Israel) IV LP
 Pontifax (Israel) IV LP Financial ConglomeratesFinance Part of Pontifax Management Co. Ltd., Pontifax (Israel) IV LP is an investment services provider. The company is based in Hertsliya, Israel and was founded in 2015. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| ELOXX PHARMACEUTICALS, INC. | Biotechnology | Chairman Director/Board Member | |
| Pontifax Management 4 Gp 2015 Ltd. | Corporate Officer/Principal Corporate Officer/Principal | ||
| PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member | |
ADCendo ApS
 ADCendo ApS BiotechnologyHealth Technology ADCendo ApS is a Danish company that is focused on developing antibody-drug conjugates (ADCs) to treat underserved cancers. The company is based in Humlebaek, Denmark. The company completed a series A extension financing round in 2023, which brought its funds to 82 million EUR to advance into clinical development. The investors in the company include Novo Holdings, Ysios Capital, Pontifax Venture Capital, RA Capital Management, HealthCap, and Gilde Healthcare. The company was founded in 2017 by Christoffer Nielsen, Henrik Stage. Michael Pehl has been the CEO of the company since 2021. | Biotechnology | Chairman Director/Board Member | |
Stimatix G.I. Ltd.
 Stimatix G.I. Ltd. Electronic Equipment/InstrumentsElectronic Technology Stimatix GI Ltd. engages in the field of gastroenterology. It developes an Artificial Ostomy Sphincter (AOS) technology which is designed to address the needs of individuals with colostomies, by holistically restoring the various physiological, behavioral and aesthetical functions of healthy anus and rectum. The company was founded by David Hanuka and Meir Or in June 2009 and is headquartered in Misgav, Israel. | Electronic Equipment/Instruments | Chairman Director/Board Member | |
Indapta Therapeutics, Inc.
 Indapta Therapeutics, Inc. BiotechnologyHealth Technology Indapta Therapeutics, Inc. operates as a biotechnology company. It focuses on developing and commercializing a proprietary, first-in-class, off-the-shelf allogeneic cell therapy to treat multiple types of difficult-to-treat hematologic cancers and solid tumors. The company was founded by Guy DiPierro, Ronald A. Martell, Sungjin Kim and John Sunwoo in 2017 and is headquartered in Houston, TX. | Biotechnology | Director/Board Member |
Statistics
International
| Israel | 22 |
| United States | 18 |
| France | 6 |
| Belgium | 3 |
| Denmark | 2 |
Sectoral
| Health Technology | 31 |
| Finance | 7 |
| Consumer Services | 6 |
| Health Services | 3 |
| Producer Manufacturing | 2 |
Operational
| Director/Board Member | 319 |
| Chairman | 54 |
| Corporate Officer/Principal | 42 |
| Independent Dir/Board Member | 38 |
| Private Equity Investor | 37 |
Most connected contacts
| Insiders | |
|---|---|
| Tomer Kariv | 46 |
| Zeev Bronfeld | 46 |
| Ran Nussbaum | 38 |
| Chahra Khaoua Epouse Louafi | 26 |
| François Thomas | 25 |
| Marten Steen | 21 |
| Catherine Boule | 18 |
| Ruth Devenyns | 18 |
| Aristotelis Nastos | 17 |
| John Sørensen Haurum | 17 |
| Pini Orbach | 16 |
| Karl Nägler | 16 |
| Dominik Escher | 15 |
| Gerald D. Cagle | 15 |
| Christina Takke | 14 |
- Stock Market
- Insiders
- Ohad Hammer
- Company connections
